Anticoagulation management and risk of thromboembolism in healthy youth with atrial fibrillation: Data from a multi-institutional PACES collaborative registry

Heart Rhythm. 2022 Nov;19(11):1916-1917. doi: 10.1016/j.hrthm.2022.07.018. Epub 2022 Aug 4.

Authors

Iqbal El Assaad¹, Benjamin H Hammond¹, Peter F Aziz²; Participating Members of the Pediatric and Congenital Electrophysiology Society¹

Collaborators

Participating Members of the Pediatric and Congenital Electrophysiology Society:
Christopher Janson, Elizabeth Dr Sherwin, Elizabeth A Stephenson, Christopher L Johnsrude, Mary Niu, Ira Shetty, David Lawrence, Anthony C McCanta, Seshadri Balaji, Shubhayan Sanatani, Frank Fish, Gregory Webster

Affiliations

¹ Department of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland, Ohio.
² Department of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland, Ohio. Electronic address: azizp@ccf.org.

PMID: 35932986
DOI: 10.1016/j.hrthm.2022.07.018

No abstract available

Keywords: Anticoagulation; Atrial fibrillation; Pediatrics; Stroke; Thromboembolism.

Publication types

Multicenter Study

MeSH terms

Adolescent
Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Blood Coagulation
Humans
Registries
Risk Factors
Stroke*
Thromboembolism* / epidemiology
Thromboembolism* / etiology
Thromboembolism* / prevention & control

Substances

Anticoagulants